Characterized BRCA1 and BRCA2 Proteins and Screening and Therapeutic Methods Based on Characterized BRCA1 and BRCA2 Proteins

Summary

Therapeutic methods for the treatment of prostate cancer are described. The methods include a gene therapy method for prostate cancer using the BRCA family of genes, including the BRCA1 and BRCA2 genes. The BRCA family of gene products inhibit the growth and tumorigenesis of prostate cancer cells. Therapeutic methods using the BRCA family of gene products are also described.

Patent

U.S. Patent 6,177,410: Therapeutic methods for prostate cancer

U.S. Patent 5,891,857: Characterized BRCA1 and BRCA2 proteins and screening and therapeutic methods based on characterized BRCA1 and BRCA2 proteins

Inventors: 
Jeffrey HoltRoy JensenMary-Claire KingDavid PageCsilla SzaboTom JettonCheryl Robinson-BenionMarilyn ThompsonMitchell SteinerPatrice Obermiller
Licensing manager: 
Janis Elsner

Featured Video

Vanderbilt Patent Activity

View Vanderbilt University Patents

CTTC on Twitter